Russell Lebovitz
individual
About
Russell Lebovitz, MD, PhD, is the CEO and founder of Amprion, a neurodegenerative-disease diagnostics company focused on seed amplification assays and biomarker-based testing. He is a physician-scientist by training, with prior faculty roles at Baylor College of Medicine and Fox Chase Cancer Center. Public sources place him in the Alzheimer's and broader neurodegeneration diagnostics ecosystem as an operator, collaborator, and speaker rather than an investor.
Areas of interest
biotechclinical diagnosticsneurodegenerationAlzheimer's diseaseParkinson's diseaseLewy body dementiabiomarkersbrain health drug development